A prostate-specific membrane antigen-targeted monoclonal antibody–chemotherapeutic conjugate designed for the treatment of prostate cancer

MD Henry, S Wen, MD Silva, S Chandra, M Milton… - Cancer research, 2004 - AACR
MLN2704 is an antibody-chemotherapeutic conjugate designed to target prostate-specific
membrane antigen (PSMA). PSMA is a transmembrane receptor whose expression is …
被引用次数：233 相关文章

A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer

MD Henry, S Wen, MD Silva, S Chandra… - Cancer …, 2004 - pubmed.ncbi.nlm.nih.gov
MLN2704 is an antibody-chemotherapeutic conjugate designed to target prostate-specific
membrane antigen (PSMA). PSMA is a transmembrane receptor whose expression is …
[PDF] academia.edu

[PDF][PDF] A Prostate-Specific Membrane Antigen-Targeted Monoclonal Antibody–Chemotherapeutic Conjugate Designed for the Treatment of Prostate Cancer

MD Henry, S Wen, MD Silva, S Chandra… - CANCER …, 2004 - academia.edu
ABSTRACT MLN2704 is an antibody-chemotherapeutic conjugate designed to target
prostate-specific membrane antigen (PSMA). PSMA is a transmembrane receptor whose …

[引用][C] A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer

MD HENRY, S WEN, MD SILVA… - Cancer research …, 2004 - pascal-francis.inist.fr
A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic
conjugate designed for the treatment of prostate cancer CNRS Inist Pascal-Francis CNRS …

A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer.

MD Henry, S Wen, MD Silva, S Chandra, M Milton… - Cancer …, 2004 - europepmc.org
MLN2704 is an antibody-chemotherapeutic conjugate designed to target prostate-specific
membrane antigen (PSMA). PSMA is a transmembrane receptor whose expression is …

A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer

MD Henry, S Wen, MD Silva, S Chandra… - … research (Chicago, Ill …, 2004 - iro.uiowa.edu
MLN2704 is an antibody-chemotherapeutic conjugate designed to target prostate-specific
membrane antigen (PSMA). PSMA is a transmembrane receptor whose expression is …
[PDF] academia.edu

[PDF][PDF] A Prostate-Specific Membrane Antigen-Targeted Monoclonal Antibody–Chemotherapeutic Conjugate Designed for the Treatment of Prostate Cancer

MD Henry, S Wen, MD Silva, S Chandra… - CANCER …, 2004 - academia.edu
ABSTRACT MLN2704 is an antibody-chemotherapeutic conjugate designed to target
prostate-specific membrane antigen (PSMA). PSMA is a transmembrane receptor whose …

[引用][C] A prostate-specific membrane antigen-targeted monoclonal antibody-chemotherapeutic conjugate designed for the treatment of prostate cancer

MD HENRY, WEN SHENGHUA… - Cancer …, 2004 - American Association for Cancer …